Published in Am J Epidemiol on August 01, 1982
Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer (1987) 2.73
Antidepressants and breast and ovarian cancer risk: a review of the literature and researchers' financial associations with industry. PLoS One (2011) 1.50
Breast cancer recurrence risk in relation to antidepressant use after diagnosis. Breast Cancer Res Treat (2007) 1.31
The effects of tricyclic antidepressants on breast cancer risk. Br J Cancer (2002) 1.04
Oral Spironolactone in Post-teenage Female Patients with Acne Vulgaris: Practical Considerations for the Clinician Based on Current Data and Clinical Experience. J Clin Aesthet Dermatol (2012) 0.92
Spironolactone and risk of incident breast cancer in women older than 55 years: retrospective, matched cohort study. BMJ (2012) 0.86
Spironolactone use and risk of incident cancers: a retrospective, matched cohort study. Br J Clin Pharmacol (2016) 0.79
Nonhormonal drugs and cancer. Environ Health Perspect (1995) 0.77
Cardiac glycosides use and the risk and mortality of cancer; systematic review and meta-analysis of observational studies. PLoS One (2017) 0.75
Pattern Alopecia during Hormonal Anticancer Therapy in Patients with Breast Cancer. Ann Dermatol (2014) 0.75
Does thyroid dysfunction increase the risk of breast cancer? A systematic review and meta-analysis. J Endocrinol Invest (2017) 0.75
A Review of hormone-based therapies to treat adult acne vulgaris in women. Int J Womens Dermatol (2017) 0.75
Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med (1996) 11.91
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Antidepressants and suicide. BMJ (1995) 4.84
A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med (1996) 4.69
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Evaluation of smoking prohibition policy in a health maintenance organization. Am J Public Health (1986) 4.08
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Comprehensive drug surveillance. JAMA (1970) 2.92
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin: the ALERT extension study. Am J Transplant (2005) 2.01
Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1977) 2.00
Omeprazole, other antiulcer drugs and newly diagnosed gout. Br J Clin Pharmacol (1997) 1.99
Case-control studies in the evaluation of drug-induced illness. Am J Epidemiol (1978) 1.88
Antidepressant drugs and suicide. J Clin Psychopharmacol (1992) 1.80
The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics (1998) 1.79
Acute liver injury associated with nonsteroidal anti-inflammatory drugs and the role of risk factors. Arch Intern Med (1994) 1.79
Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom. Eur J Clin Microbiol Infect Dis (2000) 1.75
The epidemic of endometrial cancer: a commentary. Am J Public Health (1980) 1.74
Vaginal spermicides and congenital disorders. JAMA (1981) 1.74
Sexually transmitted diseases and tubal pregnancy. Sex Transm Dis (1991) 1.69
Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68
Postmenopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol (1998) 1.66
Coffee and myocardial infarction. N Engl J Med (1973) 1.66
Fatal drug reactions among medical inpatients. JAMA (1971) 1.64
The demand for eating disorder care. An epidemiological study using the general practice research database. Br J Psychiatry (1996) 1.63
The risk of venous thromboembolism in users of postcoital contraceptive pills. Contraception (1999) 1.62
Pregnancies and terminations after 1995 warning about third-generation oral contraceptives. Lancet (1998) 1.61
Growth of Streptococcus mutans in a chemostat. Arch Oral Biol (1974) 1.61
The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Med Care (1990) 1.61
Evaluation of drug efficacy by a preference technic. N Engl J Med (1966) 1.60
Haemophilus influenzae vaccine. Br J Gen Pract (1995) 1.59
A review of epidemiologic research on drug-induced acute liver injury using the general practice research data base in the United Kingdom. Pharmacotherapy (1997) 1.55
Vasectomy and non-fatal myocardial infarction. Lancet (1981) 1.54
Drug-related deaths among medical inpatients. JAMA (1977) 1.53
Diuretic drug use and the risk for hip fracture. Ann Intern Med (1991) 1.52
Magnesium-limited growth of Aerobacter aerogenes in a chemostat. J Gen Microbiol (1965) 1.46
First trimester topical tretinoin and congenital disorders. Lancet (1993) 1.45
Drug-induced gastrointestinal bleeding. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet (1978) 1.45
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982. JAMA (1986) 1.45
Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer. Arch Intern Med (2000) 1.44
Guidelines for Good Epidemiology Practices for drug, device, and vaccine research in the United States. Pharmacoepidemiol Drug Saf (1996) 1.43
The influence of temperature and pH value on the macro-molecular composition of magnesium-limited and glycerol-limited Aerobacter aerogenes growing in a chemostat. J Gen Microbiol (1965) 1.43
Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: a population-based case-control study. Am J Epidemiol (1994) 1.41
Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives. Obstet Gynecol (1992) 1.40
Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol (1984) 1.38
Incidence of first-time idiopathic seizures in users of tramadol. Pharmacotherapy (2000) 1.38
Prostate cancer in relation to the use of electric blanket or heated water bed. Epidemiology (1999) 1.38
Intensive hospital monitoring study of intravenous cimetidine. Arch Intern Med (1986) 1.38
Vaginal douching as a risk factor for acute pelvic inflammatory disease. Obstet Gynecol (1993) 1.37
Temporal and regional variation in hysterectomy rates in the United States, 1970--1975. Am J Epidemiol (1979) 1.37
Tamoxifen and risk of idiopathic venous thromboembolism. Br J Clin Pharmacol (1998) 1.36
Adverse reactions to trimethoprim-sulfamethoxazole in hospitalized patients. Rev Infect Dis (1982) 1.35
Cholestatic hepatitis associated with flucloxacillin. Med J Aust (1993) 1.34
First-trimester drug use and congenital disorders. JAMA (1981) 1.34
Drug-induced anaphylaxis, convulsions, deafness, and extrapyramidal symptoms. Lancet (1977) 1.33
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Oral contraceptives and breast cancer. Am J Epidemiol (1980) 1.32
Vasectomy and prostate cancer: a case-control study in a health maintenance organization. Am J Epidemiol (1996) 1.28
Comparison of self-report data and medical records data: results from a case-control study on prostate cancer. Int J Epidemiol (1999) 1.27
Assessment of adverse reactions within a drug surveillance program. JAMA (1968) 1.23
Vaginal douching as a risk factor for cervical Chlamydia trachomatis infection. Obstet Gynecol (1998) 1.23
Cancer of the corpus uteri: increasing incidence in the United States, 1970--1975. Am J Epidemiol (1979) 1.22
Control of persistent ventricular ectopic beats by alprenolol, a new beta-adrenergic blocking agent. Am Heart J (1969) 1.21
Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol (1999) 1.20
Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA (1976) 1.20
Risk of idiopathic venous thromboembolism in users of progestagens alone. Lancet (1999) 1.20
Use of selective serotonin reuptake inhibitors and risk of developing first-time acute myocardial infarction. Br J Clin Pharmacol (2001) 1.19
Computer analysis of epidemiologic data on effect of drugs on hospital patients. Public Health Rep (1969) 1.19